These results suggested that depletion of TRAF4 increased the sensitivity of CRC cells to radiotherapy, and the mechanism may be associated with the reduction of Bcl-xL in TRAF4-null cells. This evidence concerns the gene BCL2L1 and colorectal carcinoma.